Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Fasenra
Fasenra
AstraZeneca, working to grow Fasenra’s reach, touts positive trial against GSK's Nucala in new use
AstraZeneca, working to grow Fasenra’s reach, touts positive trial against GSK's Nucala in new use
Fierce Pharma
AstraZeneca
Fasenra
clinical trials
GSK
Nucala
eosinophilic asthma
Flag link:
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
Clinical Trials Arena
AstraZeneca
Fasenra
GSK
Nucala
eosinophilic granulomatosis with polyangiitis
clinical trials
Flag link:
Weak data for Fasenra undermine AZ’s ambitions for the drug
Weak data for Fasenra undermine AZ’s ambitions for the drug
Pharmaphorum
AstraZeneca
Fasenra
eosinophilic asthma
chronic rhinosinusitis with nasal polyps
eosinophilic esophagitis
Flag link:
AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’
AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’
Endpoints
pharma marketing
DTC advertising
AstraZeneca
eosinophilic asthma
asthma
Fasenra
Flag link:
FDA says no to AZ’s Fasenra for nasal polyp indication
FDA says no to AZ’s Fasenra for nasal polyp indication
Pharmaforum
AstraZeneca
Fasenra
nasal polyps
Flag link:
AstraZeneca's Fasenra spares asthma patients from steroid use in large trial
AstraZeneca's Fasenra spares asthma patients from steroid use in large trial
Fierce Pharma
AstraZeneca
asthma
Fasenra
clinical trials
Flag link:
AstraZeneca's asthma drug succeeds late-stage study
AstraZeneca's asthma drug succeeds late-stage study
Reuters
AstraZeneca
Fasenra
asthma
nasal polyps
clinical trials
Flag link:
FDA green lights AstraZeneca's asthma drug Fasenra for self-administration
FDA green lights AstraZeneca's asthma drug Fasenra for self-administration
Yahoo/Reuters
AstraZeneca
FDA
asthma
Fasenra
Flag link:
AstraZeneca’s Fasenra gets FDA ODD status for eosinophilic oesophagitis
AstraZeneca’s Fasenra gets FDA ODD status for eosinophilic oesophagitis
Pharmaceutical Business Review
AstraZeneca
Fasenra
orphan drugs
FDA
eosinophilic esophagitis
Flag link:
AstraZeneca respiratory business gets boost from 3-drug inhaler results
AstraZeneca respiratory business gets boost from 3-drug inhaler results
Yahoo/Reuters
AstraZeneca
Fasenra
Breztri
COPD
Flag link:
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis
Fierce Pharma
AstraZeneca
Fasenra
severe asthma
asthma
clinical trials
Flag link:
AstraZeneca’s asthma drug Fasenra looks promising for a set of rare chronic immune diseases
AstraZeneca’s asthma drug Fasenra looks promising for a set of rare chronic immune diseases
Endpoints
AstraZeneca
Fasenra
asthma
HES
FDA
Flag link:
Astrazeneca's Fasenra Gets Orphan Drug Designation for Autoimmune Disease
Astrazeneca's Fasenra Gets Orphan Drug Designation for Autoimmune Disease
Yahoo/Zacks.com
AstraZeneca
Fasenra
orphan drugs
FDA
eosinophilic granulomatosis with polyangiitis
Flag link:
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
Fierce Pharma
AstraZeneca
COPD
Fasenra
asthma
Flag link:
NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used
NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used
Fierce Pharma
AstraZeneca
Fasenra
GSK
Nucala
NICE
asthma
Flag link:
AstraZeneca drug Fasenra fails to achieve main goal in COPD trial
AstraZeneca drug Fasenra fails to achieve main goal in COPD trial
Yahoo/Reuters
AstraZeneca
Fasenra
COPD
clinical trials
Flag link:
AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD
AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD
CP Wire
AstraZeneca
MedImmune
Fasenra
COPD
Flag link:
AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD
AstraZeneca
Fasenra
COPD
Flag link:
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Endpoints
AstraZeneca
Lynparza
Merck
ovarian cancer
asthma
Japan
Fasenra
EA Pharma
elobixibat
Flag link:
GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca
GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca
Fierce Pharma
GSK
Nucala
AstraZeneca
Fasenra
eosinophilic asthma
asthma
Flag link: